spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online January 10, 2007
doi: 10.1242/10.1242/dev.02754


Development 134, 591-600 (2007)
Published by The Company of Biologists 2007


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, G. B.
Right arrow Articles by van Meyel, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, G. B.
Right arrow Articles by van Meyel, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The glycosyltransferase Fringe promotes Delta-Notch signaling between neurons and glia, and is required for subtype-specific glial gene expression

Graham B. Thomas1 and Donald J. van Meyel2,3,4,*

1 Graduate Program in Neurological Sciences, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada.
2 Centre for Research in Neuroscience, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada.
3 Department of Neurology and Neurosurgery, McGill University, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada.
4 McGill University Health Centre Research Institute, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada.


Figure 1
View larger version (113K):
[in this window]
[in a new window]

 
Fig. 1. Fng expression in a subset of longitudinal glia (LG). (A-C) Dorsal view of the nervous system of a filleted wild-type embryo at stage 16-17. (A) Anti-HRP (green) reveals the brain lobes (asterisks) and the major axon tracts of the VNC. (B) Repo-positive lateral glia (magenta). (C) Overlay of A and B. (D) Three segments of the VNC of a htl-Gal4, UAS-nGFP embryo. Anti-HRP (green) shows the anterior and posterior commissures in each segment, and the two longitudinal connectives over which the LG (anti-GFP, magenta) are positioned. (E) The six most anterior LG in each hemisegment express Pros (magenta), as do a small number of neurons (arrow). (F) Overlay of D and E without anti-HRP. Note that the Pros channel in D has been converted to green in F, clarifying the distinction between the anterior LG, which express Pros (white), and posterior LG, which do not (magenta). (G) Whole-mount fng in situ hybridization of a stage 15 embryo. Transcripts for fng are observed in a two rows of cells at the dorsal surface of the VNC. (H) Fluorescence in situ hybridization for fng (red), showing a single hemisegment with axons (anti-HRP, blue) and the commissures labeled. (I) The six anterior LG coexpress fng mRNA (red) and Repo (green). Anterior is at the top in all panels of all figures. Scale bars: 50 µm in A for A-C; 10 µm in D for D-F. AC, anterior commissure; PC, posterior commissure.

 

Figure 2
View larger version (80K):
[in this window]
[in a new window]

 
Fig. 2. Mutations in fng cause defects of Pros expression in LG. All panels except C and F show three segments of stage 15-16 VNC stained with anti-HRP (green) and co-stained for either Pros or ß-galactosidase, as indicated (magenta). (A) fngL73 heterozygotes, like wild type, have six Pros-positive LG per hemisegment. (B) The reporter loco-lacZ reveals the number and position of LG in fng heterozygotes. (C) Overlay of D and E without anti-HRP, and with Pros converted to green. (D) fng mutants have fewer Prospositive LG, and the level of Pros expression is often reduced. (E) The number and position of LG in fng mutants appears normal. (F) Overlay of D and E. (G) fngDf/+ hemizygotes also have six Pros-positive LG per hemisegment as normal. (H) Reduced Pros expression in an fng13/Df embryo (D). (I) Pros expression is rescued in fng13/Df mutants using repo-Gal4 to express UAS-fng. (J) Quantification of Pros-positive LG per hemisegment. Every Pros-expressing cell in the vicinity of the neuropil was counted as positive, regardless of staining intensity. The number of abdominal hemisegments counted for each genotype is indicated (N). Because one of the six Pros-expressing LG per hemisegment is often obscured in the compiled images, the results were binned as five or six Prosexpressing LG, versus four or fewer.

 

Figure 3
View larger version (81K):
[in this window]
[in a new window]

 
Fig. 3. Expression of N and its ligands in the VNC. (A-F) Stage 15 embryo (genotype repo-Gal4;UAS-mCD8GFP) co-labeled for N (red), GFP (blue) and HRP (green). (A) N is found on most neurons and is highly expressed in the neuropil. (B,C) Single optical section dorsal to the neuropil reveals N expression (red) along the perimeter of many LG marked by the membrane-targeted GFP. (B',C') In a cross-section through LG and the longitudinal connectives, N co-localizes with the membrane of LG (arrowheads) and channel glia (arrow). (D,E) N expression overlaps with anti-HRP in the dorsal neuropil (arrowheads in E), while HRP is excluded from glia (F). The dotted line in B indicates the anteroposterior (a-p) level of the cross-section in B',C', and D-F. The dotted line in B' indicates the dorsoventral (d-v) level of section for B and C. (G) Dl expression in a cluster of cells (arrow) near the lateral edge of the VNC of a stage 15-16 embryo. (H) Dl is expressed on proximal axons (arrowheads in G,H) although it is largely excluded from the distal axons in the region of the longitudinal connectives. (I) Ser is expressed on the cell bodies (arrowheads) and axons of two or three neurons in each hemisegment. Scale bar: 10 µm. (J) Cartoon depicting a summary of the expression of N, Dl and Ser relative to expression of Pros in the anterior LG.

 

Figure 4
View larger version (74K):
[in this window]
[in a new window]

 
Fig. 4. N activity specifically influences Pros expression in LG. All panels show three segments of a stage 15-16 VNC with axons (anti-HRP) shown in green in A,C,G,H. All other antibodies are as labeled. htl-Gal4 was used to drive expression of UAS transgenes. (A) Misexpression of Hairless (H) abolishes nearly all Pros expression in LG, while Pros in neurons is unaffected (arrowhead). (B) Overlay of Pros in A with anti-GFP reveals that H does not alter the number or positioning of LG. (C) Misexpression of Numb also abolishes Pros expression. (D,E) In wild type, the enzyme Gs2 is restricted to the six anterior LG. (F) In contrast to Pros, Gs2 expression in the anterior LG is unaffected by misexpression of Numb. (G) Misexpression of NICD causes Pros expression in most or all LG, but does not alter the number or position of LG (H). (I) Overlay of G and H without anti-HRP and with Pros converted to green. (J) Quantification of Pros-positive LG per hemisegment: misexpression studies. Quantification performed as in Fig. 2J, with results binned as shown in the legend.

 

Figure 5
View larger version (123K):
[in this window]
[in a new window]

 
Fig. 5. Pros expression in LG depends on Dl-N signaling through neuron-glial interactions. All panels (except C and H) show three segments of a stage 15-16 VNC with the axon tracts shown in green (anti-HRP) and Pros in magenta. (A) Misexpression of UAS-fng with htl-Gal4 leads to ectopic expression of Pros in posterior LG, labeled 7 and 8. (B,C) Ectopic Pros is also observed upon misexpression of either Dl (B) or Ser (not shown) in postmitotic neurons using elavC155-Gal4. (C) Co-labeling for Pros (green) and the LG marker Distal-less (magenta) shows that the ectopic Prospositive cells are indeed posterior LG. (D) By contrast, Pros is inhibited upon misexpression of Dl in LG with htl-Gal4. (E) Pros expression in fng mutants is further reduced in embryos also heterozygous for Dlrev10 (compare with Fig. 2D). (F) Pros expression is unaffected in Serrev2-11/SerRx82 mutants. (G) Fewer cells express Pros in embryos in which misexpression of UAS-Tom is driven by scrt11-6-Gal4 in neuronal lineages. (H) Three segments of a stage 16-17 embryo with scrt11-6-Gal4 driving UAS-Tom. Anti-Eve immunochemistry revealed no transformations of cell fate of RP2 (arrows) or other Eve-positive neurons. (I) Pros expression is unaffected by Tom misexpression in LG.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2007